Barrier Reverse Convertible

Symbol: BROBKB
ISIN: CH1261618800
Issuer:
Basler Kantonalbank
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 101.22
Diff. absolute / % 0.19 +0.19%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Barrier Reverse Convertible
ISIN CH1261618800
Valor 126161880
Symbol BROBKB
Quotation in percent Yes
Coupon p.a. 17.00%
Coupon Premium 12.11%
Coupon Yield 4.89%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 05/03/2024
Date of maturity 05/09/2025
Last trading day 28/08/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Dirty
Issuer Basler Kantonalbank

Key data

Ask Price (basis for calculation) 102.3100
Maximum yield 18.58%
Maximum yield p.a. 16.30%
Sideways yield 18.58%
Sideways yield p.a. 16.30%

market maker quality Date: 15/07/2024

Average Spread 0.80%
Last Best Bid Price 100.94 %
Last Best Ask Price 101.75 %
Last Best Bid Volume 250,000
Last Best Ask Volume 250,000
Average Buy Volume 250,000
Average Sell Volume 250,000
Average Buy Value 252,922 USD
Average Sell Value 254,947 USD
Spreads Availability Ratio 100.00%
Quote Availability 100.00%

Underlyings

Name Pfizer Inc. Johnson & Johnson Moderna Inc.
ISIN US7170811035 US4781601046 US60770K1079
Price 27.05 EUR 137.95 EUR 116.38 EUR
Date 16/07/24 20:42 16/07/24 20:43 16/07/24 20:43
Cap 27.04 USD 161.55 USD 97.48 USD
Distance to Cap 2.29 -10.8 28.3
Distance to Cap in % 7.81% -7.16% 22.50%
Is Cap Level reached No No No
Barrier 13.2496 USD 79.1595 USD 47.7652 USD
Distance to Barrier 16.0804 71.5905 78.0148
Distance to Barrier in % 54.83% 47.49% 62.02%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.